146 related articles for article (PubMed ID: 36558976)
1. Formulation of Multicomponent Chrysin-Hydroxy Propyl β Cyclodextrin-Poloxamer Inclusion Complex Using Spray Dry Method: Physicochemical Characterization to Cell Viability Assessment.
Imam SS; Alshehri S; Mahdi WA; Alotaibi AM; Alhwaifi MH; Hussain A; Altamimi MA; Qamar W
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558976
[TBL] [Abstract][Full Text] [Related]
2. Formulation of multicomponent inclusion complex of cyclodextrin-amino acid with Chrysin: Physicochemical characterization, cell viability and apoptosis assessment in human primary glioblastoma cell line.
Mahdi WA; Alanazi MM; Imam SS; Alshehri S; Hussain A; Altamimi MA; Alhudaithi SS
Int J Pharm X; 2023 Dec; 6():100211. PubMed ID: 37736236
[TBL] [Abstract][Full Text] [Related]
3. Formulation of Silymarin-β Cyclodextrin-TPGS Inclusion Complex: Physicochemical Characterization, Molecular Docking, and Cell Viability Assessment against Breast Cancer Cell Lines.
Imam SS; Alshehri S; Altamimi MA; Mahdi WA; Qamar W
ACS Omega; 2023 Sep; 8(38):34898-34907. PubMed ID: 37779986
[TBL] [Abstract][Full Text] [Related]
4. Formulation and Evaluation of Supramolecular Food-Grade Piperine HP β CD and TPGS Complex: Dissolution, Physicochemical Characterization, Molecular Docking, In Vitro Antioxidant Activity, and Antimicrobial Assessment.
Imam SS; Alshehri S; Alzahrani TA; Hussain A; Altamimi MA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066657
[TBL] [Abstract][Full Text] [Related]
5. Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment.
Zafar A; Alruwaili NK; Imam SS; Alsaidan OA; Alkholifi FK; Alharbi KS; Mostafa EM; Alanazi AS; Gilani SJ; Musa A; Alshehri S; Rawaf A; Alquraini A
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959278
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of cefuroxime axetil with β-cyclodextrin: Physicochemical characterization, molecular modeling and effect of l-arginine on complexation.
Sapte S; Pore Y
J Pharm Anal; 2016 Oct; 6(5):300-306. PubMed ID: 29403996
[TBL] [Abstract][Full Text] [Related]
7. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
8. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
Yurtdaş-Kırımlıoğlu G
Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
[TBL] [Abstract][Full Text] [Related]
9. Chrysin-phospholipid complex-based solid dispersion for improved anti-aging and neuroprotective effects in mice.
Salama A; Elgohary R; Kassem AA; Asfour MH
Pharm Dev Technol; 2023 Jan; 28(1):109-123. PubMed ID: 36593750
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
Jablan J; Szalontai G; Jug M
J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory Effects of Soluplus® on Flufenamic Acid β-Cyclodextrin Supramolecular Complex: Physicochemical Characterization and Pre-clinical Anti-inflammatory Assessment.
Alshehri S; Imam SS; Altamimi MA; Hussain A; Shakeel F; Alshehri A
AAPS PharmSciTech; 2020 May; 21(5):145. PubMed ID: 32430787
[TBL] [Abstract][Full Text] [Related]
12. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
13. Formulating Ternary Inclusion Complex of Sorafenib Tosylate Using β-Cyclodextrin and Hydrophilic Polymers: Physicochemical Characterization and In Vitro Assessment.
Donthi MR; Munnangi SR; Krishna KV; Marathe SA; Saha RN; Singhvi G; Dubey SK
AAPS PharmSciTech; 2022 Sep; 23(7):254. PubMed ID: 36109473
[TBL] [Abstract][Full Text] [Related]
14. Characterization, Preparation, and Promotion of Plant Growth of 1,3-Diphenylurea/β-Cyclodextrin Derivatives Inclusion Complexes.
Yamamoto K; Tanikawa T; Tomita J; Ishida Y; Nakata D; Terao K; Inoue Y
ACS Omega; 2023 Sep; 8(38):34972-34981. PubMed ID: 37779935
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin Complexation Improves the Solubility and Caco-2 Permeability of Chrysin.
Fenyvesi F; Nguyen TLP; Haimhoffer Á; Rusznyák Á; Vasvári G; Bácskay I; Vecsernyés M; Ignat SR; Dinescu S; Costache M; Ciceu A; Hermenean A; Váradi J
Materials (Basel); 2020 Aug; 13(16):. PubMed ID: 32824341
[TBL] [Abstract][Full Text] [Related]
17. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
[TBL] [Abstract][Full Text] [Related]
18. Complexation with Random Methyl-β-Cyclodextrin and (2-Hydroxypropyl)-β-Cyclodextrin Promotes Chrysin Effect and Potential for Liver Fibrosis Therapy.
Ignat SR; Dinescu S; Váradi J; Fenyvesi F; Nguyen TLP; Ciceu A; Hermenean A; Costache M
Materials (Basel); 2020 Nov; 13(21):. PubMed ID: 33171970
[TBL] [Abstract][Full Text] [Related]
19. Improving the Solubilization and Bioavailability of Arbidol Hydrochloride by the Preparation of Binary and Ternary β-Cyclodextrin Complexes with Poloxamer 188.
Anwer MK; Iqbal M; Ahmed MM; Aldawsari MF; Ansari MN; Ezzeldin E; Khalil NY; Ali R
Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33926020
[TBL] [Abstract][Full Text] [Related]
20. Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin-Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics.
Hermenean A; Dossi E; Hamilton A; Trotta MC; Russo M; Lepre CC; Sajtos C; Rusznyák Á; Váradi J; Bácskay I; Budai I; D'Amico M; Fenyvesi F
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
